Results 191 to 200 of about 3,472,654 (379)
Treatment ofClostridium difficileInfection [PDF]
Dale N. Gerding +2 more
openalex +1 more source
Abstract Background Current treatment options for equine gastric ulcer syndrome (EGUS), such as omeprazole—a proton pump inhibitor (PPI)—have notable limitations, including the need for administration on an empty stomach. Potassium‐competitive acid blockers (P‐CABs), such as vonoprazan, are a newer class of acid suppressants that offer several ...
Camilo J. Morales +4 more
wiley +1 more source
Bacteriophage therapy is characterised by numerous advantages, facilitating its diverse aquaculture application and efficacy as an antibiotic alternative mitigating the spread of antimicrobial‐resistant pathogens. Contributing to the modern reappraisal of the aquaculture application of bacteriophage therapy, challenges impeding its widespread ...
Louise James +4 more
wiley +1 more source
Clostridium difficile infections and fidaxomicin treatment
Laura Fascio Pecetto
doaj +1 more source
Editorial Commentary: Community-Associated Clostridium difficile Infection in Children [PDF]
Philip Toltzis, Theo Zaoutis
openalex +1 more source
Diagnosis of Clostridium difficile Infections in Children
Stella Antonara, A. Leber
semanticscholar +1 more source
EHD4 and ASAP2 are critical negative regulators of the claudin‐5‐based endothelial barrier
Cell‐surface CLDN‐5 protein levels can be evaluated using a probe that can bind to the extracellular domains of CLDN‐5. A probe derived from Clostridium perfringens enterotoxin allows us to isolate cells with high CLDN‐5 protein levels from a knockout cell library.
Yosuke Hashimoto +8 more
wiley +1 more source

